The Oral Irrigator Market, valued at USD 1,065.2 million in 2023, is poised for significant expansion, projected to reach USD ...

The data uncover broad optimism as well as stark regional disparities and cultural obstacles in the West that must be ...

Scalable, User-Friendly Data Management Solution Offers Innovation, Integration, and Transparency for Pharma Operations. SOFIA, BG / ACCESS Newswire / January 20, 2025 / A leading global ...

What is Biodefense?Biodefense Market refers to strategies and technologies designed to protect populations from biological threats, including bioterrorism and accidental biological exposures. The use ...

WEST PALM BEACH, FL / ACCESS Newswire / January 20, 2025 / Ethema Health Corporation (OTCPINK:GRST) ("Ethema" "GRST" or the "Company"), is pleased to announce its participation in The Microcap ...

Innovative Trials, a specialist clinical trial patient engagement, recruitment, and retention company, has today, Monday 20 January 2025, announced John Watkinson MBE as its first-ever Non-Executive ...

UMRANIYE, TR / ACCESS Newswire / January 20, 2025 / Smile Hair Clinic is proud to announce its position as a leader in the ...

Issuer Direct Corp Re-names and Re-brands as ACCESS Newswire Inc.: A Bold Step Toward the Future of CommunicationsTopic:Company Name ChangeThursday, 16 January 2025 09:02 AMOn January 27, 2025, Issuer ...

New analysis indicating that healthcare treatment needs to be boosted by a fifth to eliminate COVID backlogs could represent ‘a huge incentive to ambitious innovators’, insists an NHS Scotland partner ...

The 39th PM Society Awards will take place on Friday 14th March, 2025, supported by Avalere Health. This is the longest running and largest awards event in the pharma marketing and healthcare agency ...

The Best Places to Work organization is proud to announce the Top 25 Best Places to Work in Europe for 2024, recognizing the most outstanding employers who have demonstrated exceptional commitment to ...

GSK plc (LSE/NYSE: GSK) today announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...